Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Non-invasive magnetic resonance spectroscopy assessment of brain metabolic changes following neuronal reprogramming

EF 2024-25

Résumé
With neurological disorders like Alzheimer disease on the rise in Canada, especially due to an aging population, there is an urgent need for treatments that help people maintain their ability to perform daily tasks. Alzheimer is linked to the loss of neurons, potentially caused by astrocytes;one of the most abundant brain cells;that can become toxic when activated. Currently, there are no effective treatments to slow or reverse neurodegeneration in Alzheimer disease. A treatment approach that we are proposing is to use neuronal reprogramming, which involves directly converting activated astrocytes into induced neurons (iNeurons) to compensate for neuronal loss. This approach could help restore lost neurons and reduce the harmful effects of astrocytes that contribute to disease progression. To ensure the viability of this method, reliable and non-invasive biomarkers are needed to monitor the reprogramming process. Magnetic resonance spectroscopy (MRS) is a technique that can detect chemical changes in the brain, providing insights into the ongoing metabolic processes. Since astrocytes and iNeurons use different processes for energy production, these metabolic changes can be evaluated to determine the conversion of astrocytes into iNeurons. Thus, the goal of this project is to develop an MRS-based technique for the assessment of metabolic changes following neuronal reprogramming in both human brain tissue models and rodent models. If successful, this assessment technique can later be refined for application in humans.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530017
Name
Faylinn Christabel
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Non-invasive magnetic resonance spectroscopy assessment of brain metabolic changes following neuronal reprogramming
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Astrocyte-To-Neuron Conversion; Energy Metabolism; Induced Neurons; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Metabolic Biomarkers; Neurodegenerative Diseases; Neurological Disorders; Neuronal Reprogramming; Nuclear Magnetic Resonance Spectroscopy
Abstract
With neurological disorders like Alzheimer disease on the rise in Canada, especially due to an aging population, there is an urgent need for treatments that help people maintain their ability to perform daily tasks. Alzheimer is linked to the loss of neurons, potentially caused by astrocytes;one of the most abundant brain cells;that can become toxic when activated. Currently, there are no effective treatments to slow or reverse neurodegeneration in Alzheimer disease. A treatment approach that we are proposing is to use neuronal reprogramming, which involves directly converting activated astrocytes into induced neurons (iNeurons) to compensate for neuronal loss. This approach could help restore lost neurons and reduce the harmful effects of astrocytes that contribute to disease progression. To ensure the viability of this method, reliable and non-invasive biomarkers are needed to monitor the reprogramming process. Magnetic resonance spectroscopy (MRS) is a technique that can detect chemical changes in the brain, providing insights into the ongoing metabolic processes. Since astrocytes and iNeurons use different processes for energy production, these metabolic changes can be evaluated to determine the conversion of astrocytes into iNeurons. Thus, the goal of this project is to develop an MRS-based technique for the assessment of metabolic changes following neuronal reprogramming in both human brain tissue models and rodent models. If successful, this assessment technique can later be refined for application in humans.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Faylinn, Christabel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~